Hélénon O, Merran S, Paraf F, Melki P, Correas J M, Chrétien Y, Moreau J F
Department of Radiology, Necker Hospital, Paris, France.
Radiographics. 1997 Jan-Feb;17(1):129-44. doi: 10.1148/radiographics.17.1.9017804.
Unusual fat-containing renal tumors in a series of 27 cases comprised five categories: atypical and complicated angiomyolipomas (AMLs) (n = 15), including AMLs with extrarenal growth (n = 5), AMLs with undetectable fat (n = 4), and hemorrhagic AMLs (n = 6); fat-containing renal cell carcinomas (RCCs) (n = 9); lipoma (n = 1); liposarcoma (n = 1); and fat-containing renal oncocytoma (n = 1). Fat was present within RCCs by the following mechanisms; lipid-producing necrosis within a large RCC (n = 2), intratumoral bone metaplasia with fatty marrow elements and calcification within a small RCC (n = 2), and entrapment of perirenal (n = 4) or sinus (n = 1) fat by large irregular RCCs. Fat-containing RCC must be considered in cases of fat-containing renal tumors, even though the presence of intratumoral fat is characteristic of AML. A dedicated computed tomography scanning protocol and strict diagnostic criteria are mandatory for accurate diagnosis. Malignancy should be suspected on the basis of the following criteria: presence of intratumoral calcifications; large, irregular tumor invading the perirenal or sinus fat; large necrotic tumor with small foci of fat; and association with nonfatty lymph nodes or venous invasion.
27例特殊含脂肪肾肿瘤分为五类:非典型和复杂血管平滑肌脂肪瘤(AML)(n = 15),包括肾外生长的AML(n = 5)、脂肪不可见的AML(n = 4)和出血性AML(n = 6);含脂肪肾细胞癌(RCC)(n = 9);脂肪瘤(n = 1);脂肪肉瘤(n = 1);含脂肪肾嗜酸细胞瘤(n = 1)。RCC内脂肪的存在有以下机制:大RCC内的脂质生成性坏死(n = 2)、小RCC内伴有脂肪骨髓成分和钙化的瘤内骨化生(n = 2),以及大的不规则RCC包绕肾周(n = 4)或肾窦(n = 1)脂肪。含脂肪肾肿瘤病例中必须考虑含脂肪RCC,尽管瘤内脂肪的存在是AML的特征。准确诊断需要专门的计算机断层扫描方案和严格的诊断标准。基于以下标准应怀疑恶性肿瘤:瘤内钙化的存在;侵犯肾周或肾窦脂肪的大的不规则肿瘤;有小脂肪灶的大坏死肿瘤;以及与无脂肪的淋巴结或静脉侵犯相关。